Greater Cannabis Company (GCAN) Gains from Investment Securities (2017 - 2018)
Greater Cannabis Company (GCAN) recorded quarterly Gains from Investment Securities of $10000.0 in Q2 2018, little changed quarter-over-quarter from $10000.0 in Q1 2018.
Greater Cannabis Company (GCAN) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Greater Cannabis Company's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $10000.0 for Q2 2018.
- In Q2 2018, Gains from Investment Securities changed N/A year-over-year to $10000.0; the TTM figure through Jun 2018 stood at $10000.0 (changed N/A YoY), while the FY2017 annual figure was $10000.0, changed N/A from the prior year.
- Gains from Investment Securities was $10000.0 for Q2 2018 at Greater Cannabis Company, roughly flat from $10000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $10000.0 in Q3 2017 to a low of $10000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Greater Cannabis Company | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 10,000.00 |
| Jun 30, 2018 | 10,000.00 |
| Mar 31, 2018 | 10,000.00 |
| Mar 31, 2018 | 10,000.00 |
| Dec 31, 2017 | 10,000.00 |
| Dec 31, 2017 | 10,000.00 |
| Sep 30, 2017 | 10,000.00 |
| Sep 30, 2017 | 10,000.00 |